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A B S T R A C T
Objective: To estimate the annual risk of HIV transmission (f) within HIV sero-discordant couples in 23
countries in sub-Saharan Africa (SSA), by utilizing newly available national population-based data and
accounting for factors known to potentially affect this estimation.
Methods: We used a recently developed pair-based mathematical model that accommodates for HIV-
dynamics temporal variation, sexual risk-behavior heterogeneity, and antiretroviral therapy (ART) scale-
up.
Results: Estimated country-speciﬁc f (in absence of ART) ranged between 4.2% (95% uncertainty interval
(UI): 1.9%-6.3%) and 47.4% (95% UI: 37.2%-69.0%) per person-year (ppy), with a median of 12.4%. f was
strongly associated with HIV prevalence, with a Pearson correlation coefﬁcient of 0.92, and was larger in
high- versus low-HIV-prevalence countries. f increased by 1.31% (95% conﬁdence interval: 1.00%-1.55%)
ppy for every 1% increase in HIV prevalence.
Conclusions: f estimates were similar to earlier estimates, and suggested considerable heterogeneity in
HIV infectiousness across SSA. This heterogeneity may explain, partly, the differences in epidemic scales.
© 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Introduction
Quantifying the annual risk of HIV transmission (f) within HIV
sero-discordant couples (SDCs) in sub-Saharan Africa (SSA) is
critical to understanding HIV epidemiology and implementation of
intervention programs. Previously, we estimated f and its
variation and found that it varies across countries (Chemaitelly
et al., 2014). We also found that f is within the range, but overall
higher, than that estimated in setting-speciﬁc longitudinal studies
following cohorts of SDCs in Africa (Chemaitelly et al., 2014).
A key limitation in earlier estimates is that the modeling
approach did not factor the temporal variation in HIV prevalence,
sexual risk-behavior heterogeneity, and scale-up of antiretroviral
therapy (ART). Although the spatial dimension does not appear to
play a critical role in sero-discordancy dynamics (Cuadros and
Abu-Raddad, 2016), historical and future patterns of sero-
discordancy were found dependent on the temporal changes in
HIV epidemics (Awad et al., 2017).
We present here new estimates for f in 23 SSA countries using
an elaborate modeling approach that accommodates for epidemic
temporal variation, sexual risk-behavior heterogeneity, and ART
scale-up. The new estimates also utilize all rounds of the nationally
representative household surveys, the Demographic and Health
Surveys (DHS) (MEASURE DHS, 2017), for each country in SSA up to
2015.
Methods
A pair-based model was used to estimate the mean f over the
duration of the modeled epidemics. Brieﬂy, the model consists of a
set of coupled nonlinear differential equations stratifying the
population according to stable-couple status, risk-behavior group,
HIV status, and ART-treatment status (Awad et al., 2017). The
model accommodated for epidemic temporal variation, in its
different phases, and for the risk of acquiring the infection from
other non-stable partners (i.e. through extramarital sex). Ten risk
groups, a sexual-risk mixing matrix, and temporal changes in risk
behavior were also incorporated to account for heterogeneity and
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declines in risk of HIV exposure (Awad et al., 2017; Awad and Abu-
Raddad, 2014). The country-speciﬁc ART coverage was set as
reported (UNAIDS, 2015b), and ART reduced the overall HIV
infectiousness (by 96% (Cohen et al., 2011)) and slowed disease
progression (Awad et al., 2017).
Countries were included based on availability of DHS sero-
prevalence surveys to apply the model to these data (MEASURE
DHS, 2017). The model was parameterized using natural history
and epidemiology data from SSA (Awad et al., 2017). We estimated
f by ﬁtting the country-speciﬁc 1990-2015 HIV prevalence and
sero-discordancy measures (MEASURE DHS, 2017; Chemaitelly
et al., 2012). All measures were weighted equally in the ﬁtting.
Multivariate uncertainty analysis was conducted for the model
structural parameters, and the country-speciﬁc f mean and 95%
uncertainty interval (UI) were estimated using a log-normal ﬁt.
Association between the country-speciﬁc HIV prevalence and
estimated f was assessed using linear regression.
Further details about this model and its parameterization can
be found elsewhere (Awad et al., 2017).
Results
Table S1 in the online version, at DOI:10.1016/j.ijid.2017.10.022,
shows the derived DHS HIV prevalence and sero-discordancy
measures that were ﬁtted using the model. Estimated country-
speciﬁc f (in absence of ART) ranged between 4.2% (95% UI:
1.9%-6.3%) and 47.4% (95% UI: 37.2%-69.0%) per person-year (ppy),
with a median of 12.4% ppy (Figure 1). The median was 9.4% ppy in
low-HIV-prevalence countries (HIV prevalence 5%) and 25.2%
ppy in high-HIV-prevalence countries (HIV prevalence >5%).
Figure 2 illustrates the association between the estimated f and
HIV prevalence in 2015, with Burundi and Rwanda excluded as
outliers. f was strongly correlated with HIV prevalence—Pearson
correlation coefﬁcient of 0.92 with HIV prevalence explaining 85%
of the variation. f increased by 1.31% (95% conﬁdence interval:
1.00%-1.55%) ppy for every 1% increase in HIV prevalence
(p-value < 0.001). The correlation was also assessed with HIV
prevalence in earlier years, to capture the correlation at different
epidemic phases. The correlation coefﬁcient increased steadily
with year, and was strong for all years starting from the mid-1990s.
For example, the correlation coefﬁcient was 0.88 with HIV
prevalence in 2000, thereby explaining 77% of the variation.
Discussion
We presented new estimates of HIV infectiousness within SDCs
in 23 SSA countries. Despite the new analytical approach and
updated input data, f estimates were similar to those estimated
earlier (Figure 1; p-value for difference in overall mean = 0.71)
(Chemaitelly et al., 2014). The estimated f values indicated also
large variability in infectiousness across countries. The contrasting
HIV epidemic trajectories in SSA are possibly a consequence of the
variability in f—HIV prevalence in different epidemic phases was
strongly associated with HIV infectiousness (Figure 2). This
highlights how f is high and needs to be addressed in high HIV
prevalence countries, such as in Swaziland with a f of 47% ppy and
HIV prevalence of 29%. As more quality population-based data
become available over the coming years, it will be useful to update
these estimates based on more comprehensive data from more
survey rounds.
Our estimates for f are roughly within the range of estimates
from longitudinal studies, of 1.2%-22.0% ppy (Chemaitelly et al.,
2014)—but higher on average. The lower observed f in longitutal
studies may be explained by known biases, such as higher levels of
Figure 1. Mean and 95% uncertainty interval for the country-speciﬁc annual risk of HIV transmission (f) from the infected to the uninfected partner in a stable HIV sero-
discordant couple across sub-Saharan Africa. The blue bars indicate the predictions of Chemaitelly et al. (2014), while the red bars indicate the predictions of the present study.
Countries are shown by sub-region (UNICEF, 2008) and in order of increasing 2015 HIV prevalence. HIV prevalence in 2015 is based on UNAIDS estimates (UNAIDS, 2015a).
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sero-status disclosure and intense counseling, in the studied
cohorts versus the population at large, as well as selection bias of
more “resistant” and “surviving” couples in the recruitment of
SDCs (Chemaitelly et al., 2014).
The observed variability in f across countries is supported by a
body of evidence indicating a role for biological cofactors in HIV
transmission such as male circumcision (Weiss et al., 2008),
co-infections (whether sexually transmitted or not) (Korenromp
et al., 2001; Abu-Raddad et al., 2006; Abu-Raddad et al., 2012),
variation in the susceptibility to HIV (Nagelkerke et al., 2009; Kaul
et al., 2011), virus sub-type (Novitsky et al., 2011), and hormonal
contraception use (Heffron et al., 2012). Behavioral factors may
also play a role such as variations in uptake of condom use (Hughes
et al., 2012) and coital frequency (Brown, 2000). While our study
estimated the overall mean f across epidemic evolution, it would
be of interest in future studies to investigate how these multiple
cofactors could have affected f’s variation across countries and
over time.
Our study has limitations. We assumed a speciﬁc level of sexual
mixing between risk groups based on earlier work (Abu-Raddad
and Longini, 2008), but this assumption had no impact on the
estimated f, as demonstrated in a sensitivity analysis (Figure S1 in
the online version, at DOI:10.1016/j.ijid.2017.10.022). We assumed
that f was constant during the observed time frame (1980-2030),
but prevalence of cofactors affecting f, such as male circumcision,
may have changed over time—the estimated f is simply an overall
average over the modeled epidemic duration. Burundi and Rwanda
were excluded from the regression analysis because of very high f
relative to HIV prevalence—possibly because of too small and non-
representative SDC datasets.
In summary, HIV infectiousness within sexual partnerships
appears to vary by country probably due to a combination of
biological and behavioral cofactors. This heterogeneity may
explain, partly, the differences in the scales of SSA epidemics.
This cumulative and consistent evidence for heterogeneity in
infectiousness may underline a hallmark of the epidemiology of
HIV—the extensive geographical variability in transmission pat-
terns in comparison to other infections.
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